We support the development of effective and equitable EDS and HSD therapies, and our goal is to ensure consistent and ground-breaking research into the complexities of these conditions.
We need to understand the best ways to treat symptoms, how the conditions develop and progress over time, the genetic causes behind hypermobile EDS and hypermobility spectrum disorders, the prevalence of all types of EDS and HSD, and the association between EDS, HSD, and conditions such as postural orthostatic tachycardia syndrome and mast cell activation syndrome.
By funding researchers, we can support them to reveal vital clues to beat EDS and HSD and improve quality of life for all. We aim to award $1million annually in research grants.
Dr. Cortney Gensemer Ph.D. closed the third day of the 2022 International Scientific Symposium in Rome, Italy, this year, presenting research as part of exciting session on advances in genetic research in hypermobile Ehlers-Danlos syndrome. Here, she explains why The Ehlers-Danlos Society is important for both researchers and those living with these conditions.
View funded research and grant award information here: [ Ссылка ]
